10.04.24 -- Capacity, AI Driving Single-Use Bioprocess Probe And Sensor Uptake

Current advances in cell, gene, and tissue therapies require a rethinking of how—and where—cleanroom manufacturing facilities could be built, enabling more options for sponsor process control.

Surplus and idle equipment can lead to decreases in workspace and work efficiencies for a manufacturing site. Learn how you can get paid for them and clean up your workspaces.

Process optimization is key to achieving effective pharmaceutical and cosmetic critical cleaning. Learn how manufacturers can improve cleaning efficiency and ensure product safety.

Explore the importance of biological indicators and why they should be integral to any comprehensive sterilization program.

Tailored CMC services can lead to shorter global licensing timelines and minimize variability in globally registered product details.

Discover how single-use bioreactors ensure seamless process development to production with consistent yields and quality.

Explore antibody development and production, the processes and steps involved, and the screening and selection of antibody candidates.

This analytical instrument, designed to analyze AAV samples, can precisely determine the empty/full capsid ratio in samples of any serotype in a cost-effective, simple to operate way.

Explore safety measures for handling mAbs in production in order to meet strict requirements that prevent contamination, product loss and exposure to cytotoxic agents or radioisotopes.

In this blog we outline a development program that could tailor accordingly to meet your final product platform needs, with target cell lot size foremost in mind.

Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.

Drug development is a long and complex process, and every step has specific goals. Explore the relevant objectives and techniques used in each stage of antibody drug development.

Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.

Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks.

Explore the needs of more complex candidates, through case studies that demonstrate the range of expression capabilities across mammalian and microbial-derived molecules.

This poster reviews studies for three monoclonal antibody drug candidates utilizing a panel of small scale, fast, and predictive tests used to evaluate therapeutic antibodies’ developability.

In an industry where unplanned downtime during manufacturing can be catastrophic, having the right maintenance support for the specialized equipment supporting a biopharmaceutical workflow is crucial.

There are various factors that require careful consideration throughout the process of formulating LNPs and utilizing them for successful mRNA delivery and translation.